Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Wall Street in Fives - Must Read Lists for Friday » 16:20
06/04/21
06/04
16:20
06/04/21
16:20
PSTH

Pershing Square Tontine Holdings

$22.06 /

-2.97 (-11.87%)

, VIVHY

Vivendi

$35.46 /

+0.01 (+0.03%)

, FB

Facebook

$330.21 /

+4.09 (+1.25%)

, SQ

Square

$213.71 /

+2.3 (+1.09%)

, AMC

AMC Entertainment

$48.00 /

-3.025 (-5.93%)

, ODP

ODP Corporation

$49.61 /

+5.06 (+11.36%)

, BBBY

Bed Bath & Beyond

$31.70 /

-0.23 (-0.72%)

, GME

GameStop

$248.14 /

-8.86 (-3.45%)

, NOC

Northrop Grumman

$377.58 /

+11.33 (+3.09%)

, WFC

Wells Fargo

$46.96 /

+0.49 (+1.05%)

, WKHS

Workhorse Group

$13.05 /

-1.715 (-11.62%)

, WINT

Windtree Therapeutics

$2.70 /

+0.735 (+37.50%)

, SPCE

Virgin Galactic

$31.40 /

+0.38 (+1.23%)

, BMY

Bristol-Myers

$64.94 /

+0.14 (+0.22%)

, VIAC

ViacomCBS

$41.70 /

+0.13 (+0.31%)

, VIACA

ViacomCBS

$45.87 /

-0.05 (-0.11%)

, WMT

Walmart

$141.84 /

+0.26 (+0.18%)

, SENS

Senseonics

$2.91 /

+0.865 (+42.40%)

, TRGP

Targa Resources

$46.24 /

+5.07 (+12.31%)

, CLGX

CoreLogic

$80.00 /

+ (+0.00%)

, FATE

Fate Therapeutics

$72.96 /

+5.63 (+8.36%)

, CRK

Comstock Resources

$5.95 /

-0.295 (-4.72%)

, NGL

NGL Energy Partners

$2.49 /

-0.64 (-20.45%)

, ASAN

Asana

$39.19 /

+2.49 (+6.78%)

, AVGO

Broadcom

$475.18 /

+9.4 (+2.02%)

, FIVE

Five Below

$190.22 /

+12.41 (+6.98%)

, LULU

Lululemon

$329.63 /

+12.16 (+3.83%)

, PD

PagerDuty

$35.36 /

-5.295 (-13.03%)

Get caught up quickly on…

ShowHide Related Items >><<
WMT Walmart
$141.84 /

+0.26 (+0.18%)

WKHS Workhorse Group
$13.05 /

-1.715 (-11.62%)

WINT Windtree Therapeutics
$2.70 /

+0.735 (+37.50%)

WFC Wells Fargo
$46.96 /

+0.49 (+1.05%)

VIVHY Vivendi
$35.46 /

+0.01 (+0.03%)

VIACA ViacomCBS
$45.87 /

-0.05 (-0.11%)

VIAC ViacomCBS
$41.70 /

+0.13 (+0.31%)

TRGP Targa Resources
$46.24 /

+5.07 (+12.31%)

SQ Square
$213.71 /

+2.3 (+1.09%)

SPCE Virgin Galactic
$31.40 /

+0.38 (+1.23%)

SENS Senseonics
$2.91 /

+0.865 (+42.40%)

PSTH Pershing Square Tontine Holdings
$22.06 /

-2.97 (-11.87%)

PD PagerDuty
$35.36 /

-5.295 (-13.03%)

ODP ODP Corporation
$49.61 /

+5.06 (+11.36%)

NOC Northrop Grumman
$377.58 /

+11.33 (+3.09%)

NGL NGL Energy Partners
$2.49 /

-0.64 (-20.45%)

LULU Lululemon
$329.63 /

+12.16 (+3.83%)

GME GameStop
$248.14 /

-8.86 (-3.45%)

FIVE Five Below
$190.22 /

+12.41 (+6.98%)

FB Facebook
$330.21 /

+4.09 (+1.25%)

FATE Fate Therapeutics
$72.96 /

+5.63 (+8.36%)

CRK Comstock Resources
$5.95 /

-0.295 (-4.72%)

CLGX CoreLogic
$80.00 /

+ (+0.00%)

BMY Bristol-Myers
$64.94 /

+0.14 (+0.22%)

BBBY Bed Bath & Beyond
$31.70 /

-0.23 (-0.72%)

AVGO Broadcom
$475.18 /

+9.4 (+2.02%)

ASAN Asana
$39.19 /

+2.49 (+6.78%)

AMC AMC Entertainment
$48.00 /

-3.025 (-5.93%)

PSTH Pershing Square Tontine Holdings
$22.06 /

-2.97 (-11.87%)

VIVHY Vivendi
$35.46 /

+0.01 (+0.03%)

06/01/21
Fly Intel: Top five analyst downgrades
06/01/21 Bernstein
Vivendi downgraded to Market Perform from Outperform at Bernstein
05/14/21 Credit Suisse
Vivendi price target lowered to EUR 32.20 from EUR 32.40 at Credit Suisse
04/23/21 Barclays
Vivendi price target raised to EUR 32 from EUR 31 at Barclays
FB Facebook
$330.21 /

+4.09 (+1.25%)

06/03/21 Jefferies
Facebook building 'comprehensive SMB tool-set,' says Jefferies
06/03/21 Wedbush
Wedbush expects data privacy to be main focus of Apple's Cook keynote address
06/02/21 KGI Securities
Facebook initiated with an Outperform at KGI Securities
05/25/21 HSBC
Facebook price target raised to $275 from $220 at HSBC
SQ Square
$213.71 /

+2.3 (+1.09%)

05/25/21 Baird
Square comps starting to get more difficult, says Baird
05/20/21 Tigress Financial
Square shares have close to 50% upside potential, says Tigress Financial
05/10/21 BMO Capital
Square price target raised to $269 from $237 at BMO Capital
05/07/21 JPMorgan
Square price target raised to $300 from $250 at JPMorgan
AMC AMC Entertainment
$48.00 /

-3.025 (-5.93%)

06/04/21 BofA
BofA moves to No Rating on Bed Bath & Beyond amid 'meme mania'
06/04/21 Wedbush
AMC Entertainment price target raised to $7.50 from $6.50 at Wedbush
06/01/21 Loop Capital
AMC Entertainment remains massively diluted, overlevered, says Loop Capital
05/26/21
Fly Intel: Top five analyst downgrades
ODP ODP Corporation
$49.61 /

+5.06 (+11.36%)

02/25/21 UBS
ODP Corporation upgraded to Neutral from Sell at UBS
01/12/21 JPMorgan
ODP Corporation upgraded to Neutral following Staples bid at JPMorgan
01/12/21 JPMorgan
ODP Corporation upgraded to Neutral from Underweight at JPMorgan
BBBY Bed Bath & Beyond
$31.70 /

-0.23 (-0.72%)

05/18/21 Credit Suisse
Bed Bath & Beyond assumed with a Neutral at Credit Suisse
04/19/21 JPMorgan
Bed Bath & Beyond price target raised to $29 from $23 at JPMorgan
04/16/21 Loop Capital
Bed Bath & Beyond price target lowered to $24 from $30 at Loop Capital
GME GameStop
$248.14 /

-8.86 (-3.45%)

06/04/21 BofA
GameStop coverage terminated at BofA
04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 Ascendiant
GameStop downgraded to Sell from Hold at Ascendiant
NOC Northrop Grumman
$377.58 /

+11.33 (+3.09%)

06/04/21
Fly Intel: Top five analyst upgrades
06/04/21 Stifel
Stifel upgrades Northrop Grumman to Buy amid 'still-elevated' global threats
06/03/21 Stifel
Northrop Grumman upgraded to Buy from Hold at Stifel
05/12/21 Wells Fargo
Summer travel should be catalyst for commercial aero, says Wells Fargo
WFC Wells Fargo
$46.96 /

+0.49 (+1.05%)

06/04/21 BofA
BofA upgrades Wells Fargo to Buy amid 'multi-year transformation'
06/04/21 BofA
Wells Fargo upgraded to Buy from Neutral at BofA
05/19/21
Fly Intel: Top five analyst downgrades
WKHS Workhorse Group
$13.05 /

-1.715 (-11.62%)

06/04/21
Fly Intel: Top five analyst downgrades
06/04/21 Cowen
Workhorse Group downgraded to Market Perform from Outperform at Cowen
05/11/21 B. Riley
B. Riley cuts Workhorse target but says earnings selloff overblown
05/10/21 Roth Capital
Workhorse Group price target lowered to $8.50 from $15 at Roth Capital
WINT Windtree Therapeutics
$2.70 /

+0.735 (+37.50%)

06/04/21 Oppenheimer
Windtree Therapeutics initiated with an Outperform at Oppenheimer
06/04/21 Oppenheimer
Windtree Therapeutics initiated with an Outperform at Oppenheimer
06/26/20
Fly Intel: Top five analyst initiations
06/26/20 Ladenburg
Windtree Therapeutics initiated with a Buy at Ladenburg
SPCE Virgin Galactic
$31.40 /

+0.38 (+1.23%)

05/26/21
Fly Intel: Top five analyst initiations
05/26/21 Canaccord
Virgin Galactic initiated with a Buy at Canaccord
05/25/21 Morgan Stanley
Virgin Galactic price target lowered to $25 from $30 at Morgan Stanley
05/24/21
Fly Intel: Top five analyst upgrades
BMY Bristol-Myers
$64.94 /

+0.14 (+0.22%)

05/05/21 Wells Fargo
Wells sees 'limited impact' on Iovance's lifileucel from Keytruda/Yervoy data
04/30/21
Fly Intel: Top five analyst downgrades
04/30/21 Morgan Stanley
Bristol-Myers downgraded to Equal Weight on pipeline questions at Morgan Stanley
04/30/21 Morgan Stanley
Bristol-Myers downgraded to Equal Weight from Overweight at Morgan Stanley
VIAC ViacomCBS
$41.70 /

+0.13 (+0.31%)

05/24/21 Truist
Lionsgate price target raised to $19 from $15 at Truist
05/21/21 Citi
ViacomCBS price target lowered to $54 from $56 at Citi
05/20/21
Fly Intel: Top five analyst upgrades
05/20/21 BofA
ViacomCBS upgraded to Buy from Underperform at BofA
VIACA ViacomCBS
$45.87 /

-0.05 (-0.11%)

01/05/21 Gabelli
ViacomCBS named a best idea for 2021 at Gabelli
07/13/20
Fly Intel: Top five analyst initiations
07/13/20
Fly Intel: Top five analyst downgrades
WMT Walmart
$141.84 /

+0.26 (+0.18%)

05/24/21 Morgan Stanley
Target price target raised to $250 from $205 at Morgan Stanley
05/19/21 MKM Partners
Walmart price target raised to $152 from $141 at MKM Partners
05/19/21 Morgan Stanley
Walmart price target raised to $160 from $154 at Morgan Stanley
05/19/21 Wells Fargo
Walmart capitalizes on improving consumer environment, says Wells Fargo
SENS Senseonics
$2.91 /

+0.865 (+42.40%)

04/01/21
Fly Intel: Top five analyst downgrades
04/01/21 SVB Leerink
Senseonics downgraded to Market Perform after diabetes deep dive at SVB Leerink
04/01/21 SVB Leerink
Senseonics downgraded to Market Perform from Outperform at SVB Leerink
03/05/21 Stifel
Senseonics price target raised to $2.50 from $1 at Stifel
TRGP Targa Resources
$46.24 /

+5.07 (+12.31%)

06/03/21 Barclays
Targa Resources price target raised to $54 from $43 at Barclays
05/14/21 RBC Capital
Targa Resources price target raised to $50 from $39 at RBC Capital
05/12/21 Mizuho
Targa Resources price target raised to $42 from $36 at Mizuho
05/07/21 Citi
Targa Resources price target raised to $45 from $37 at Citi
CLGX CoreLogic
$80.00 /

+ (+0.00%)

03/05/21 Keefe Bruyette
CoStar decision to walk removes overhang on shares, says Keefe Bruyette
02/04/21 Stephens
CoreLogic accepting $80 bid 'a bit of an odd twist,' says Stephens
01/06/21 Wolfe Research
CoreLogic downgraded to Underperform from Peer Perform at Wolfe Research
12/01/20 Truist
CoreLogic downgraded to Hold from Buy at Truist
FATE Fate Therapeutics
$72.96 /

+5.63 (+8.36%)

06/04/21 Roth Capital
Fate Therapeutics duration response remains unknown, says Roth Capital
06/04/21 Piper Sandler
Fate's Phase I data showed 8 patients achieved ORR, says Piper Sandler
04/26/21 Jefferies
Fate Therapeutics assumed with a Buy at Jefferies
03/04/21 Wells Fargo
Fate Therapeutics price target raised to $130 from $84 at Wells Fargo
CRK Comstock Resources
$5.95 /

-0.295 (-4.72%)

04/20/21 Mizuho
Comstock Resources price target lowered to $8 from $9 at Mizuho
03/23/21 Citi
Comstock Resources price target lowered to $7 from $8 at Citi
03/15/21 Piper Sandler
Comstock Resources downgraded to Neutral from Overweight at Piper Sandler
01/11/21 Mizuho
Comstock Resources price target lowered to $7 from $11 at Mizuho
NGL NGL Energy Partners
$2.49 /

-0.64 (-20.45%)

02/18/21 UBS
NGL Energy Partners upgraded to Neutral from Sell at UBS
10/16/20 UBS
NGL Energy Partners downgraded to Sell from Neutral at UBS
07/22/20 Wells Fargo
NGL Energy Partners downgraded to Underweight at Wells Fargo
07/22/20 Wells Fargo
NGL Energy Partners downgraded to Underweight from Equal Weight at Wells Fargo
ASAN Asana
$39.19 /

+2.49 (+6.78%)

06/04/21 RBC Capital
Asana price target raised to $45 from $39 at RBC Capital
06/04/21 KeyBanc
Asana price target raised to $48 from $40 at KeyBanc
06/04/21 JMP Securities
Asana price target raised to $50 from $40 at JMP Securities
06/04/21 Piper Sandler
Asana price target raised to $52 from $45 at Piper Sandler
AVGO Broadcom
$475.18 /

+9.4 (+2.02%)

06/04/21 Morgan Stanley
Broadcom price target raised to $555 from $538 at Morgan Stanley
06/04/21 Wells Fargo
Broadcom price target raised to $475 from $450 at Wells Fargo
06/04/21 KeyBanc
Broadcom price target raised to $565 from $540 at KeyBanc
06/04/21 Mizuho
Broadcom price target raised to $520 from $490 at Mizuho
FIVE Five Below
$190.22 /

+12.41 (+6.98%)

06/04/21 RBC Capital
Five Below price target raised to $234 from $225 at RBC Capital
06/04/21 Jefferies
Five Below price target raised to $300 from $260 at Jefferies
04/27/21 Jefferies
Five Below price target raised to $260 from $250 at Jefferies
03/22/21
Fly Intel: Top five analyst downgrades
LULU Lululemon
$329.63 /

+12.16 (+3.83%)

06/04/21 B. Riley
Lululemon price target lowered to $370 from $374 at B. Riley
06/04/21 Stifel
Lululemon guidance 'leaves room for considerable upside,' says Stifel
06/04/21 Deutsche Bank
Lululemon price target raised to $401 from $390 at Deutsche Bank
06/04/21 BTIG
Lululemon price target raised to $440 from $434 at BTIG
PD PagerDuty
$35.36 /

-5.295 (-13.03%)

04/09/21 Monness Crespi
PagerDuty oversold, attractive after pullback, says Monness Crespi
03/18/21 Monness Crespi
PagerDuty price target raised to $59 from $57 at Monness Crespi
03/18/21 RBC Capital
PagerDuty price target raised to $50 from $47 at RBC Capital
03/15/21 Credit Suisse
PagerDuty assumed with a Neutral at Credit Suisse
WMT Walmart
$141.84 /

+0.26 (+0.18%)

WKHS Workhorse Group
$13.05 /

-1.715 (-11.62%)

WFC Wells Fargo
$46.96 /

+0.49 (+1.05%)

VIAC ViacomCBS
$41.70 /

+0.13 (+0.31%)

TRGP Targa Resources
$46.24 /

+5.07 (+12.31%)

SQ Square
$213.71 /

+2.3 (+1.09%)

SPCE Virgin Galactic
$31.40 /

+0.38 (+1.23%)

SENS Senseonics
$2.91 /

+0.865 (+42.40%)

PD PagerDuty
$35.36 /

-5.295 (-13.03%)

ODP ODP Corporation
$49.61 /

+5.06 (+11.36%)

NOC Northrop Grumman
$377.58 /

+11.33 (+3.09%)

NGL NGL Energy Partners
$2.49 /

-0.64 (-20.45%)

LULU Lululemon
$329.63 /

+12.16 (+3.83%)

GME GameStop
$248.14 /

-8.86 (-3.45%)

FIVE Five Below
$190.22 /

+12.41 (+6.98%)

FB Facebook
$330.21 /

+4.09 (+1.25%)

FATE Fate Therapeutics
$72.96 /

+5.63 (+8.36%)

CRK Comstock Resources
$5.95 /

-0.295 (-4.72%)

CLGX CoreLogic
$80.00 /

+ (+0.00%)

BMY Bristol-Myers
$64.94 /

+0.14 (+0.22%)

BBBY Bed Bath & Beyond
$31.70 /

-0.23 (-0.72%)

AVGO Broadcom
$475.18 /

+9.4 (+2.02%)

ASAN Asana
$39.19 /

+2.49 (+6.78%)

AMC AMC Entertainment
$48.00 /

-3.025 (-5.93%)

  • 04
    Jun
  • 06
    Apr
  • 29
    Mar
  • 23
    Mar
  • 24
    Mar
  • 22
    Jan
  • 06
    Jan
  • 20
    Aug
  • 06
    Aug
  • 22
    Jul
  • 09
    Jun
WMT Walmart
$141.84 /

+0.26 (+0.18%)

WKHS Workhorse Group
$13.05 /

-1.715 (-11.62%)

WFC Wells Fargo
$46.96 /

+0.49 (+1.05%)

VIVHY Vivendi
$35.46 /

+0.01 (+0.03%)

VIACA ViacomCBS
$45.87 /

-0.05 (-0.11%)

VIAC ViacomCBS
$41.70 /

+0.13 (+0.31%)

SQ Square
$213.71 /

+2.3 (+1.09%)

SPCE Virgin Galactic
$31.40 /

+0.38 (+1.23%)

PSTH Pershing Square Tontine Holdings
$22.06 /

-2.97 (-11.87%)

ODP ODP Corporation
$49.61 /

+5.06 (+11.36%)

NOC Northrop Grumman
$377.58 /

+11.33 (+3.09%)

LULU Lululemon
$329.63 /

+12.16 (+3.83%)

GME GameStop
$248.14 /

-8.86 (-3.45%)

FB Facebook
$330.21 /

+4.09 (+1.25%)

CLGX CoreLogic
$80.00 /

+ (+0.00%)

BMY Bristol-Myers
$64.94 /

+0.14 (+0.22%)

BBBY Bed Bath & Beyond
$31.70 /

-0.23 (-0.72%)

AVGO Broadcom
$475.18 /

+9.4 (+2.02%)

AMC AMC Entertainment
$48.00 /

-3.025 (-5.93%)

WMT Walmart
$141.84 /

+0.26 (+0.18%)

WKHS Workhorse Group
$13.05 /

-1.715 (-11.62%)

WFC Wells Fargo
$46.96 /

+0.49 (+1.05%)

VIAC ViacomCBS
$41.70 /

+0.13 (+0.31%)

SQ Square
$213.71 /

+2.3 (+1.09%)

SPCE Virgin Galactic
$31.40 /

+0.38 (+1.23%)

SENS Senseonics
$2.91 /

+0.865 (+42.40%)

PSTH Pershing Square Tontine Holdings
$22.06 /

-2.97 (-11.87%)

PD PagerDuty
$35.36 /

-5.295 (-13.03%)

ODP ODP Corporation
$49.61 /

+5.06 (+11.36%)

NOC Northrop Grumman
$377.58 /

+11.33 (+3.09%)

LULU Lululemon
$329.63 /

+12.16 (+3.83%)

GME GameStop
$248.14 /

-8.86 (-3.45%)

FIVE Five Below
$190.22 /

+12.41 (+6.98%)

FB Facebook
$330.21 /

+4.09 (+1.25%)

FATE Fate Therapeutics
$72.96 /

+5.63 (+8.36%)

CLGX CoreLogic
$80.00 /

+ (+0.00%)

BMY Bristol-Myers
$64.94 /

+0.14 (+0.22%)

BBBY Bed Bath & Beyond
$31.70 /

-0.23 (-0.72%)

AVGO Broadcom
$475.18 /

+9.4 (+2.02%)

ASAN Asana
$39.19 /

+2.49 (+6.78%)

AMC AMC Entertainment
$48.00 /

-3.025 (-5.93%)

WMT Walmart
$141.84 /

+0.26 (+0.18%)

WKHS Workhorse Group
$13.05 /

-1.715 (-11.62%)

WFC Wells Fargo
$46.96 /

+0.49 (+1.05%)

VIAC ViacomCBS
$41.70 /

+0.13 (+0.31%)

SQ Square
$213.71 /

+2.3 (+1.09%)

SPCE Virgin Galactic
$31.40 /

+0.38 (+1.23%)

SENS Senseonics
$2.91 /

+0.865 (+42.40%)

PSTH Pershing Square Tontine Holdings
$22.06 /

-2.97 (-11.87%)

NOC Northrop Grumman
$377.58 /

+11.33 (+3.09%)

LULU Lululemon
$329.63 /

+12.16 (+3.83%)

GME GameStop
$248.14 /

-8.86 (-3.45%)

FB Facebook
$330.21 /

+4.09 (+1.25%)

BMY Bristol-Myers
$64.94 /

+0.14 (+0.22%)

BBBY Bed Bath & Beyond
$31.70 /

-0.23 (-0.72%)

AVGO Broadcom
$475.18 /

+9.4 (+2.02%)

ASAN Asana
$39.19 /

+2.49 (+6.78%)

AMC AMC Entertainment
$48.00 /

-3.025 (-5.93%)

On The Fly
Fly Intel: Pre-market Movers » 09:00
06/04/21
06/04
09:00
06/04/21
09:00
SENS

Senseonics

$2.04 /

-0.045 (-2.16%)

, WINT

Windtree Therapeutics

$1.96 /

+0.06 (+3.16%)

, RCAT

Red Cat

$2.47 /

-0.03 (-1.20%)

, HOFT

Hooker Furniture

$37.59 /

+0.5 (+1.35%)

, ASAN

Asana

$36.68 /

-0.15 (-0.41%)

, NGL

NGL Energy Partners

$3.13 /

+0.355 (+12.79%)

, SUMO

Sumo Logic

$18.65 /

-0.34 (-1.79%)

, QTRX

Quanterix

$53.56 /

+2.52 (+4.94%)

, PSTH

Pershing Square Tontine Holdings

$25.02 /

+0.11 (+0.44%)

, AMC

AMC Entertainment

$51.03 /

-12.915 (-20.20%)

, FIVE

Five Below

$177.89 /

-2.08 (-1.16%)

Check out this morning's…

ShowHide Related Items >><<
WINT Windtree Therapeutics
$1.96 /

+0.06 (+3.16%)

SUMO Sumo Logic
$18.65 /

-0.34 (-1.79%)

SENS Senseonics
$2.04 /

-0.045 (-2.16%)

RCAT Red Cat
$2.47 /

-0.03 (-1.20%)

QTRX Quanterix
$53.56 /

+2.52 (+4.94%)

PSTH Pershing Square Tontine Holdings
$25.02 /

+0.11 (+0.44%)

NGL NGL Energy Partners
$3.13 /

+0.355 (+12.79%)

HOFT Hooker Furniture
$37.59 /

+0.5 (+1.35%)

FIVE Five Below
$177.89 /

-2.08 (-1.16%)

ASAN Asana
$36.68 /

-0.15 (-0.41%)

AMC AMC Entertainment
$51.03 /

-12.915 (-20.20%)

SENS Senseonics
$2.04 /

-0.045 (-2.16%)

04/01/21
Fly Intel: Top five analyst downgrades
04/01/21 SVB Leerink
Senseonics downgraded to Market Perform after diabetes deep dive at SVB Leerink
04/01/21 SVB Leerink
Senseonics downgraded to Market Perform from Outperform at SVB Leerink
03/05/21 Stifel
Senseonics price target raised to $2.50 from $1 at Stifel
WINT Windtree Therapeutics
$1.96 /

+0.06 (+3.16%)

06/04/21 Oppenheimer
Windtree Therapeutics initiated with an Outperform at Oppenheimer
06/04/21 Oppenheimer
Windtree Therapeutics initiated with an Outperform at Oppenheimer
06/26/20
Fly Intel: Top five analyst initiations
06/26/20 Ladenburg
Windtree Therapeutics initiated with a Buy at Ladenburg
RCAT Red Cat
$2.47 /

-0.03 (-1.20%)

HOFT Hooker Furniture
$37.59 /

+0.5 (+1.35%)

ASAN Asana
$36.68 /

-0.15 (-0.41%)

06/04/21 RBC Capital
Asana price target raised to $45 from $39 at RBC Capital
06/04/21 KeyBanc
Asana price target raised to $48 from $40 at KeyBanc
06/04/21 JMP Securities
Asana price target raised to $50 from $40 at JMP Securities
06/04/21 Piper Sandler
Asana price target raised to $52 from $45 at Piper Sandler
NGL NGL Energy Partners
$3.13 /

+0.355 (+12.79%)

02/18/21 UBS
NGL Energy Partners upgraded to Neutral from Sell at UBS
10/16/20 UBS
NGL Energy Partners downgraded to Sell from Neutral at UBS
07/22/20 Wells Fargo
NGL Energy Partners downgraded to Underweight at Wells Fargo
07/22/20 Wells Fargo
NGL Energy Partners downgraded to Underweight from Equal Weight at Wells Fargo
SUMO Sumo Logic
$18.65 /

-0.34 (-1.79%)

06/04/21 RBC Capital
Sumo Logic price target lowered to $25 from $30 at RBC Capital
06/04/21 BTIG
Sumo Logic price target lowered to $27 from $35 at BTIG
06/04/21 Piper Sandler
Sumo Logic price target lowered to $24 from $33 at Piper Sandler
05/25/21 Morgan Stanley
Sumo Logic price target lowered to $22 from $26 at Morgan Stanley
QTRX Quanterix
$53.56 /

+2.52 (+4.94%)

06/04/21 Goldman Sachs
Quanterix initiated with a Sell at Goldman Sachs
05/06/21 SVB Leerink
Quanterix price target lowered to $70 from $85 at SVB Leerink
03/03/21 SVB Leerink
Quanterix price target raised to $85 from $75 at SVB Leerink
03/03/21 Canaccord
Quanterix price target raised to $90 from $86 at Canaccord
PSTH Pershing Square Tontine Holdings
$25.02 /

+0.11 (+0.44%)

AMC AMC Entertainment
$51.03 /

-12.915 (-20.20%)

06/04/21 BofA
BofA moves to No Rating on Bed Bath & Beyond amid 'meme mania'
06/04/21 Wedbush
AMC Entertainment price target raised to $7.50 from $6.50 at Wedbush
06/01/21 Loop Capital
AMC Entertainment remains massively diluted, overlevered, says Loop Capital
05/26/21
Fly Intel: Top five analyst downgrades
FIVE Five Below
$177.89 /

-2.08 (-1.16%)

06/04/21 Jefferies
Five Below price target raised to $300 from $260 at Jefferies
04/27/21 Jefferies
Five Below price target raised to $260 from $250 at Jefferies
03/22/21
Fly Intel: Top five analyst downgrades
03/22/21 Evercore ISI
Evercore downgrades Five Below to In Line with stock up 70% from pre-COVID level
SUMO Sumo Logic
$18.65 /

-0.34 (-1.79%)

SENS Senseonics
$2.04 /

-0.045 (-2.16%)

QTRX Quanterix
$53.56 /

+2.52 (+4.94%)

NGL NGL Energy Partners
$3.13 /

+0.355 (+12.79%)

HOFT Hooker Furniture
$37.59 /

+0.5 (+1.35%)

FIVE Five Below
$177.89 /

-2.08 (-1.16%)

ASAN Asana
$36.68 /

-0.15 (-0.41%)

AMC AMC Entertainment
$51.03 /

-12.915 (-20.20%)

  • 30
    Apr
  • 23
    Mar
  • 04
    Feb
  • 22
    Jan
  • 17
    Sep
  • 07
    Aug
  • 22
    Jul
PSTH Pershing Square Tontine Holdings
$25.02 /

+0.11 (+0.44%)

AMC AMC Entertainment
$51.03 /

-12.915 (-20.20%)

SUMO Sumo Logic
$18.65 /

-0.34 (-1.79%)

SENS Senseonics
$2.04 /

-0.045 (-2.16%)

QTRX Quanterix
$53.56 /

+2.52 (+4.94%)

PSTH Pershing Square Tontine Holdings
$25.02 /

+0.11 (+0.44%)

FIVE Five Below
$177.89 /

-2.08 (-1.16%)

ASAN Asana
$36.68 /

-0.15 (-0.41%)

AMC AMC Entertainment
$51.03 /

-12.915 (-20.20%)

SUMO Sumo Logic
$18.65 /

-0.34 (-1.79%)

SENS Senseonics
$2.04 /

-0.045 (-2.16%)

PSTH Pershing Square Tontine Holdings
$25.02 /

+0.11 (+0.44%)

ASAN Asana
$36.68 /

-0.15 (-0.41%)

AMC AMC Entertainment
$51.03 /

-12.915 (-20.20%)

Initiation
Windtree Therapeutics initiated with an Outperform at Oppenheimer » 07:23
06/04/21
06/04
07:23
06/04/21
07:23
WINT

Windtree Therapeutics

$1.96 /

+0.06 (+3.16%)

Oppenheimer analyst…

Oppenheimer analyst Leland Gershell initiated coverage of Windtree Therapeutics with an Outperform rating and $8 price target. Lead candidate istaroxime's potential to fill an important need among higher-risk patients in acute heart failure, the most common cause of hospitalization among the elderly, is amply illustrated by prior clinical trials, Gershell tells investors in a research note. The analyst believes success in a soon-to-start Phase 2b could set the stage for a lucrative pharma partnership for pivotal development and commercialization, while efficacy in an early cardiogenic shock study could pave the way toward accelerated approval for this life-threatening syndrome.

ShowHide Related Items >><<
WINT Windtree Therapeutics
$1.96 /

+0.06 (+3.16%)

WINT Windtree Therapeutics
$1.96 /

+0.06 (+3.16%)

06/04/21 Oppenheimer
Windtree Therapeutics initiated with an Outperform at Oppenheimer
06/26/20
Fly Intel: Top five analyst initiations
06/26/20 Ladenburg
Windtree Therapeutics initiated with a Buy at Ladenburg
  • 23
    Mar
Initiation
Windtree Therapeutics initiated with an Outperform at Oppenheimer » 06:44
06/04/21
06/04
06:44
06/04/21
06:44
WINT

Windtree Therapeutics

$1.96 /

+0.06 (+3.16%)

Oppenheimer analyst…

Oppenheimer analyst Leland Gershell initiated coverage of Windtree Therapeutics with an Outperform rating and $8 price target.

ShowHide Related Items >><<
WINT Windtree Therapeutics
$1.96 /

+0.06 (+3.16%)

WINT Windtree Therapeutics
$1.96 /

+0.06 (+3.16%)

06/26/20
Fly Intel: Top five analyst initiations
06/26/20 Ladenburg
Windtree Therapeutics initiated with a Buy at Ladenburg
  • 23
    Mar
Over a quarter ago
Hot Stocks
Windtree announces new istaroxime expedited review filing of patent » 07:08
04/19/21
04/19
07:08
04/19/21
07:08
WINT

Windtree Therapeutics

$2.15 /

-0.04 (-1.83%)

Windtree Therapeutics…

Windtree Therapeutics announced it has filed a Track One prioritized application with the United States Patent and Trademark Office for a patent stemming from an application it filed previously under the Patent Cooperation Treaty. Under this USPTO program, the new istaroxime patent is expected to receive examination and final disposition within one year of priority status being granted, rather than the customary three years of examination anticipated by the USPTO for non-prioritized examinations.

ShowHide Related Items >><<
WINT Windtree Therapeutics
$2.15 /

-0.04 (-1.83%)

WINT Windtree Therapeutics
$2.15 /

-0.04 (-1.83%)

06/26/20
Fly Intel: Top five analyst initiations
06/26/20 Ladenburg
Windtree Therapeutics initiated with a Buy at Ladenburg
WINT Windtree Therapeutics
$2.15 /

-0.04 (-1.83%)

  • 23
    Mar
  • 20
    May
Syndicate
Windtree Therapeutics 9.23M share Spot Secondary priced at $3.25 » 08:34
03/23/21
03/23
08:34
03/23/21
08:34
WINT

Windtree Therapeutics

$3.83 /

-0.17 (-4.25%)

The deal priced below the…

The deal priced below the last closing price of $3.85. Oppenheimer and Ladenburg are acting as joint book running managers for the offering.

ShowHide Related Items >><<
WINT Windtree Therapeutics
$3.83 /

-0.17 (-4.25%)

WINT Windtree Therapeutics
$3.83 /

-0.17 (-4.25%)

06/26/20
Fly Intel: Top five analyst initiations
06/26/20 Ladenburg
Windtree Therapeutics initiated with a Buy at Ladenburg
WINT Windtree Therapeutics
$3.83 /

-0.17 (-4.25%)

  • 23
    Mar
  • 20
    May
Syndicate
Windtree announces common stock and warrants offering, no amount given » 16:15
03/22/21
03/22
16:15
03/22/21
16:15
WINT

Windtree Therapeutics

$3.83 /

-0.17 (-4.25%)

Windtree Therapeutics…

Windtree Therapeutics announced that it has commenced an underwritten public offering of its shares of common stock and warrants to purchase shares of common stock. Windtree intends to use the net proceeds from the proposed offering, together with other available funds, for the continued advancement of its lead product candidate istaroxime, a first-in-class, dual-acting agent being developed to improve cardiac function in patients with acute heart failure as well as in early cardiogenic shock, including for start-up activities for a second phase 2b clinical trial in acute heart failure, and for the development of its other pipeline product candidates and for working capital and general corporate purposes. Oppenheimer & Co. and Ladenburg Thalmann & Co. are acting as joint book-running managers for the offering. National Securities Corporation is acting as the lead manager for the offering.

ShowHide Related Items >><<
WINT Windtree Therapeutics
$3.83 /

-0.17 (-4.25%)

WINT Windtree Therapeutics
$3.83 /

-0.17 (-4.25%)

06/26/20
Fly Intel: Top five analyst initiations
06/26/20 Ladenburg
Windtree Therapeutics initiated with a Buy at Ladenburg
WINT Windtree Therapeutics
$3.83 /

-0.17 (-4.25%)

  • 20
    May
Hot Stocks
Windtree Therapeutics extends collaboration with University of Milan-Bicocca » 07:04
03/22/21
03/22
07:04
03/22/21
07:04
WINT

Windtree Therapeutics

$4.00 /

+0.03 (+0.76%)

Windtree Therapeutics…

Windtree Therapeutics announced the company is extending its collaboration with the University of Milan-Bicocca for the discovery and development of new SERCA2a compounds for the potential treatment of chronic and acute human heart failure. Over the next 12 months, the program will focus on the further characterization of Windtree's SERCA2a activators and their interaction with SERCA2a and associated regulatory proteins.

ShowHide Related Items >><<
WINT Windtree Therapeutics
$4.00 /

+0.03 (+0.76%)

WINT Windtree Therapeutics
$4.00 /

+0.03 (+0.76%)

06/26/20
Fly Intel: Top five analyst initiations
06/26/20 Ladenburg
Windtree Therapeutics initiated with a Buy at Ladenburg
WINT Windtree Therapeutics
$4.00 /

+0.03 (+0.76%)

  • 20
    May
Hot Stocks
Windtree Therapeutics receives U.S. patent related to AEROSURF » 07:20
02/16/21
02/16
07:20
02/16/21
07:20
WINT

Windtree Therapeutics

$5.43 /

-0.08 (-1.45%)

Windtree Therapeutics…

Windtree Therapeutics announced that the U.S. Patent and Trademark Office, or USPTO, has issued U.S. Patent No. 10,874,818, covering features of the aerosol delivery system, or ADS, for the Company's AEROSURF drug delivery device. This patent adds to the robust patent portfolio exclusively licensed to Windtree in the field of aerosolized delivery of pulmonary surfactants, alone or combined with other agents. Windtree completed design verification of the newly designed ADS platform, which utilizes the same aerosolization technology used during the phase 2 clinical program evaluating AEROSURF in treating preterm infants with Respiratory Distress Syndrome, but with improved ergonomics, interface, controls, and dose monitoring in a modular design.

ShowHide Related Items >><<
WINT Windtree Therapeutics
$5.43 /

-0.08 (-1.45%)

WINT Windtree Therapeutics
$5.43 /

-0.08 (-1.45%)

06/26/20
Fly Intel: Top five analyst initiations
06/26/20 Ladenburg
Windtree Therapeutics initiated with a Buy at Ladenburg
WINT Windtree Therapeutics
$5.43 /

-0.08 (-1.45%)

  • 20
    May
WINT Windtree Therapeutics
$5.43 /

-0.08 (-1.45%)

Hot Stocks
Windtree Therapeutics doses first patient in Phase 2 COVID-19 lung injury trial » 08:06
01/06/21
01/06
08:06
01/06/21
08:06
WINT

Windtree Therapeutics

$5.34 /

+0.22 (+4.30%)

Windtree Therapeutics has…

Windtree Therapeutics has dosed the first patient in its Phase 2 clinical trial studying lucinactant in acute lung injury in adults with COVID-19 associated lung injury and acute respiratory distress syndrome, or ARDS. Lucinactant is the company's synthetic KL4 surfactant that is structurally similar to human pulmonary surfactant. There are no approved drug therapies for ARDS, yet surfactant abnormalities are a known characteristic of the condition. The company believes its synthetic KL4 surfactant may have the potential to mitigate surfactant deficiency, improve respiratory parameters and reduce the time a patient spends on mechanical ventilation and the number of days a patient spends in the intensive care unit. The study will establish the dosing regimen, tolerability, and functional changes in gas exchange and lung compliance after KL4 surfactant administration. The study will include up to 20 patients with COVID-19 and ARDS and on mechanical ventilation from 4-5 U.S. sites. Planned outcome measures include: physiologic response - Oxygenation Index, lung compliance on the ventilator and clinical parameters including time on mechanical ventilation, days in intensive care unit and mortality, although this first study will not be powered for these measures). Recruitment is expected to take 3-6 months.

ShowHide Related Items >><<
WINT Windtree Therapeutics
$5.34 /

+0.22 (+4.30%)

WINT Windtree Therapeutics
$5.34 /

+0.22 (+4.30%)

06/26/20
Fly Intel: Top five analyst initiations
06/26/20 Ladenburg
Windtree Therapeutics initiated with a Buy at Ladenburg
WINT Windtree Therapeutics
$5.34 /

+0.22 (+4.30%)

  • 20
    May
WINT Windtree Therapeutics
$5.34 /

+0.22 (+4.30%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.